Sculptor Capital LP Clovis Oncology, Inc. Put Options Transaction History

Sculptor Capital LP

7 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q1 2022 May 13, 2022	SELL	$1.43 - $3.14 $309,309 - $679,182	-216,300 Closed	0 $0
Q2 2021 Aug 16, 2021	SELL	$5.02 - $7.05 $792,657 - $1.11 Million	-157,900 Reduced 42.2%	216,300 $1.26 Million
Q1 2021 May 14, 2021	BUY	$4.81 - $10.34 $455,987 - $980,232	94,800 Added 33.93%	374,200 $2.63 Million
Q3 2020 Nov 12, 2020	BUY	$4.82 - $7.72 $1.11 Million - $1.77 Million	229,900 Added 464.44%	279,400 $1.63 Million
Q2 2020 Aug 14, 2020	BUY	$5.69 - $9.69 $192,322 - $327,522	33,800 Added 215.29%	49,500 $334,000
Q4 2019 Feb 14, 2020	SELL	$3.0 - $16.43 $479,700 - $2.63 Million	-159,900 Reduced 91.06%	15,700 $163,000
Q3 2019 Nov 14, 2019	BUY	$3.93 - $15.35 $690,108 - $2.7 Million	175,600 New	175,600 $690,000

166

Ticker CLVS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 144,480,000
Market Cap $13M
Description
Clovis Oncology, Inc., a biopharmaceutical company, focuses on acquiring, developing, and commercializing anti-cancer agents in the United States, Europe, and internationally. In the U.S., the company offers Rubraca (rucaparib), an oral small molecule inhibitor of poly ADP-ribose polymerase for recurrent epithelial ovarian, fallopian tube, or pr...

Get notified when there are updates to the investment portfolio of Sculptor Capital LP, based on Form 13F filings with the SEC.

Stay updated on Sculptor Capital LP with notifications on news.